ELAVL1 and cancer: Overall, these findings advance the understanding of contribution of post-transcriptional control in mediating anti-inflammatory and anti-cancer effects of a class of natural compounds and expand the concept of “genome druggability” by adding the post-transcriptional activity of the RNA binding protein HuR as feasible event that can occur during a pharmacological treatment.